97 related articles for article (PubMed ID: 8215739)
1. A review of the clinical effectiveness of exercise therapy for intermittent claudication.
Ernst E; Fialka V
Arch Intern Med; 1993 Oct; 153(20):2357-60. PubMed ID: 8215739
[TBL] [Abstract][Full Text] [Related]
2. Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication.
Andreozzi GM; Leone A; Laudani R; Martin R; Deinit G; Cataldi V
Angiology; 2008; 59(1):84-9. PubMed ID: 18319227
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
4. Unbalanced risk factors, could compromise the effectiveness of physical training in patients with intermittent claudication?
Leone A; Laudani R; Definite G; Martini R; Andreozzi GM
Minerva Cardioangiol; 2009 Apr; 57(2):165-74. PubMed ID: 19274027
[TBL] [Abstract][Full Text] [Related]
5. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
6. Local versus systemic mechanisms underlying supervised exercise training for intermittent claudication.
Stewart AH; Smith FC; Baird RN; Lamont PM
Vasc Endovascular Surg; 2008; 42(4):314-20. PubMed ID: 18319355
[TBL] [Abstract][Full Text] [Related]
7. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
[TBL] [Abstract][Full Text] [Related]
8. Community trial of home-based exercise therapy for intermittent claudication.
Mouser MJ; Zlabek JA; Ford CL; Mathiason MA
Vasc Med; 2009 May; 14(2):103-7. PubMed ID: 19366815
[TBL] [Abstract][Full Text] [Related]
9. Predictors of walking distance after supervised exercise therapy in patients with intermittent claudication.
Kruidenier LM; Nicolaï SP; Ten Bosch JA; de Bie RA; Prins MH; Teijink JA
Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):449-55. PubMed ID: 19540780
[TBL] [Abstract][Full Text] [Related]
10. [Methods and results of controlled walking training in patients with peripheral arterial occlusive disease].
Cachovan M
Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):626-32. PubMed ID: 10666825
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a short-course intensive rehabilitation program in patients with moderate-to-severe intermittent claudication.
Ambrosetti M; Salerno M; Tramarin R; Pedretti RF
Ital Heart J; 2002 Aug; 3(8):467-72. PubMed ID: 12407823
[TBL] [Abstract][Full Text] [Related]
12. Treatment for intermittent claudication and the effects on walking distance and quality of life.
Kruidenier LM; Viechtbauer W; Nicolaï SP; Büller H; Prins MH; Teijink JA
Vascular; 2012 Feb; 20(1):20-35. PubMed ID: 22271802
[TBL] [Abstract][Full Text] [Related]
13. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
[TBL] [Abstract][Full Text] [Related]
15. Walking exercise in patients with intermittent claudication. Experience in routine clinical practice.
Bartelink ML; Stoffers HE; Biesheuvel CJ; Hoes AW
Br J Gen Pract; 2004 Mar; 54(500):196-200. PubMed ID: 15006125
[TBL] [Abstract][Full Text] [Related]
16. Acute impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication, and its improvement after supervised physical training.
Andreozzi GM; Leone A; Laudani R; Deinite G; Martini R
Int Angiol; 2007 Mar; 26(1):12-7. PubMed ID: 17353883
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease.
Hodges LD; Sandercock GR; Das SK; Brodie DA
Clin Physiol Funct Imaging; 2008 Jan; 28(1):32-7. PubMed ID: 18005078
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of walking capacity over time in 500 patients with intermittent claudication who underwent clinical treatment.
Wolosker N; Nakano L; Rosoky RA; Puech-Leao P
Arch Intern Med; 2003 Oct; 163(19):2296-300. PubMed ID: 14581248
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and exercise performance after aortoiliac stent placement for claudication.
Murphy TP; Soares GM; Kim HM; Ahn SH; Haas RA
J Vasc Interv Radiol; 2005 Jul; 16(7):947-53; quiz 954. PubMed ID: 16002502
[TBL] [Abstract][Full Text] [Related]
20. Determinants of walking exercise among individuals with intermittent claudication: does pain play a role?
Galea MN; Bray SR
J Cardiopulm Rehabil Prev; 2007; 27(2):107-13. PubMed ID: 17558249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
